Inverse agonist-induced up-regulation of the human β2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1479-1486

  Macewan, David J ^a   Milligan, Graeme ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALPRENOLOL; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; COMPLEMENTARY DNA; CYCLOHEXIMIDE; DIHYDROALPRENOLOL; EPHEDRINE; GUANINE NUCLEOTIDE BINDING PROTEIN; ILOPROST; ISOPRENALINE; MESSENGER RNA; SOTALOL;

ARTICLE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; HYBRID CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR UPREGULATION;

ADRENERGIC BETA-ANTAGONISTS; BETAXOLOL; GLIOMA; GTP-BINDING PROTEINS; HUMANS; HYBRID CELLS; NEUROBLASTOMA; RECEPTORS, ADRENERGIC, BETA-2; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0030473469     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 2-adrenergic receptor: extending the ternary complex model. J. Biol. Chem. 268:4625-4636 (1993).
2. Lefkowitz, R. J., S. Cotecchia, P. Samama, and T. Costa. Constitutive activity of receptors coupled to guanine-nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:303-307 (1993).
3. 2-adrenoceptor. Nature (Lond.) 374:272-276 (1995).
4. Milligan, G., R. A. Bond, and M. Lee. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci. 16: 10-13 (1995).
5. Mullaney, I., I. C. Carr, and G. Milligan. Analysis of inverse agonism at the δ opioid receptor after expression in rat 1 fibroblasts Biochem. J. 315:227-234 (1996).
6. Tiberi, M., and M. G. Caron. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J. Biol. Chem. 269:27925-27931 (1994).
7. Costa, T., and A. Herz. Antagonists with negative intrinsic activity at delta-opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. USA 86:7321-7325 (1989).
8. 2 receptor act as inverse agonists in rat myometrial cells. J. Biol. Chem. 269:25970-25973 (1994).
9. 2 adrenoceptor: evidence for empty receptor stimulation of the adenylate cyclase cascade. Biochem. J. 303:803-808 (1994).
10. Chidiac, P., T. E. Hebert, M. Valiquette, M. Dennis, and M. Bouvier. Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 45: 490-499 (1994).
11. 2-adrenergic receptor. Mol. Pharmacol. 45:390-394 (1994).
12. Gunning, P., J. Leavitt, G. Muscat, S. Y. Ng, and L. Kedes. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84:4831-4835 (1987).
13. 2 adrenoceptor. Biochem. J. 300:709-715 (1994).
14. Milligan, G. Fetal-calf serum stimulates a pertussis-toxin-sensitive highaffinity GTPase activity in rat glioma C6 BU1 cells. Biochem. J. 245:501-505 (1987).
15. Milligan, G., R. A. Streaty, P. Gierschik, A. M. Spiegel, and W. A. Klee. Development of opiate receptors and GTP-binding regulatory proteins in neonatal rat brain. J. Biol. Chem. 262:8626-8630 (1987).
16. Johnson, R. A., and Y. Salomon. Assay of adenylyl cyclase catalytic activity. Methods Enzymol. 195:3-21 (1991).
17. Johnson, R. A., R. Alvarez, and Y. Salomon. Determination of adenylyl-cyclase catalytic activity using single and double column procedures. Methods Enzymol. 238:31-56 (1994).
18. 2-adrenoceptor. Mol. Pharmacol. 48:316-325 (1995).
19. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
20. s alpha. J. Neurochem. 65:545-553 (1995).
21. 11 alpha (pertussis toxin-insensitive) G-proteins in alpha-T3-1 gonadotroph cells reflects increased G-protein turnover but not alterations in messenger-RNA levels. Proc. Natl. Acad. Sci. USA 92:1886-1890 (1995).
22. C adrenergic-receptors. J. Biol. Chem. 270:17196-17203 (1995).
23. 11 alpha following their co-expression. Biochim. Biophys. Acta 1222: 369-374 (1994).
24. 11α species variants. Mol. Pharmacol. 49:646-655 (1996).
25. Dohlman, H. G., J. Thorner, M. G. Caron, and R. J. Lefkowitz. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:653-688 (1991).
26. Lohse, M. J. Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta 1179:171-188 (1993).
27. Barker, E. L., R. S. Westphal, D. Schmidt, and E. Sanders-Bush. Constitutively active 5-hydroxytryptamine 2C (5HT2C) receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269:11687-11690 (1994).
28. Labrecque, J., A. Fargin, M. Bouvier, P. Chidiac, and M. Dennis. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Mol. Pharmacol. 48:150-159 (1995).
29. 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc. Natl. Acad. Sci. USA 91:2699-2702 (1994).
30. Kim, G. D., E. J. Adie, and G. Milligan. Quantitative stoichiometry of the proteins of the stimulatory arm of the adenylyl cyclase cascade in neuroblastoma-X-glioma hybrid, NG108-15 cells. Eur. J. Biochem. 219:135-143 (1994).
31. 2-adrenoceptor-expressing NG108-15 cells. Biochem. J. 308:275-281 (1995).
32. Kim, G. D., and G. Milligan. Receptor availability defines the extent of agonist-mediated G-protein down-regulation in neuroblastoma X glioma hybrid cells transfected to express the beta-2-adrenoceptor. FEBS Lett. 355:166-170 (1994).
33. Hadcock, J. R., and C. C. Malbon. Down-regulation of beta-adrenergic receptors: agonist-induced reduction in receptor messenger-RNA levels. Proc. Natl. Acad. Sci. USA 85:5021-5025 (1988).
34. Hadcock, J. R., and C. C. Malbon. Regulation of beta-adrenergic receptors by permissive hormones: glucocorticoids increase steady-state levels of receptor messenger-RNA. Proc. Natl. Acad. Sci. USA 85:8415-8419 (1988).
35. Hadcock, J. R., H. Y. Wang, and C. C. Malbon. Agonist-induced destabilization of beta-adrenergic-receptor messenger-RNA attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors. J. Biol. Chem. 264:19928-19933 (1989).
36. Port, J. D., L. Y. Huang, and C. C. Malbon. beta-Adrenergic agonists that down-regulate receptor messenger-RNA up-regulate a M(R) 35,000 protein(s) that selectively binds to beta-adrenergic-receptor messenger-RNAs. J. Biol. Chem. 267:24103-24108 (1992).
37. Hadcock, J. R., and C. C. Malbon. Regulation of receptor expression by agonists: transcriptional and posttranscriptional controls. Trends Neurosci. 14:242-247 (1991).
38. Collins, S, M. G. Caron, and R. J. Lefkowitz. From ligand binding to gene expression: new insights into the regulation of G protein coupled receptors. Trends Biochem. Sci. 17:37-39 (1992).